Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress
Open accessAbstract
Resveratrol, a potent natural antioxidant, possesses a wide range of pharmacological activities, but its oral bioavailability is very low due to its extensive hepatic and presystemic metabolism. The aim of the present study was to formulate a kinetically stable nanoemulsion (o/w) using vitamin E:sefsol (1:1) as the oil phase, Tween 80 as the surfactant and Transcutol P as the co-surfactant for the better management of Parkinson's disease. The nanoemulsion was prepared by a spontaneous emulsification method, followed by high-pressure homogenization. Ternary phase diagrams were constructed to locate the area of nanoemulsion. The prepared formulations were studied for globule size, zeta potential, refractive index, viscosity, surface morphology and in vitro and ex vivo release. The homogenized formulation, which contained 150 mg ml(-1) of resveratrol, showed spherical globules with an average globule diameter of 102 ± 1.46 nm, a least poly dispersity index of 0.158 ± 0.02 and optimal zeta potential values of -35 ± 0.02. The cumulative percentage drug release for the pre-homogenized resveratrol suspension, pre-homogenized nanoemulsion and post-homogenized nanoemulsion were 24.18 ± 2.30%, 54.32 ± 0.95% and 88.57 ± 1.92%, respectively, after 24 h. The ex vivo release also showed the cumulative percentage drug release of 85.48 ± 1.34% at 24 h. The antioxidant activity determined by using a DPPH assay showed high scavenging efficiency for the optimized formulation. Pharmacokinetic studies showed the higher concentration of the drug in the brain (brain/blood ratio: 2.86 ± 0.70) following intranasal administration of the optimized nanoemulsion. Histopathological studies showed decreased degenerative changes in the resveratrol nanoemulsion administered groups. The levels of GSH and SOD were significantly higher, and the level of MDA was significantly lower in the resveratrol nanoemulsion treated group.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Histopathological studies showed decreased degenerative changes in the case of resveratrol nanoemulsion administration.
“Furthermore, histopathological studies showed decreased degenerative changes in the case of resveratrol NE administration.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [58]
Nasal administration of resveratrol nanoemulsions led to a higher concentration of the drug in the brain in Wistar rats.
“Pharmacokinetic and brain-targeting studies carried out on Wistar rats demonstrated a higher concentration of the drug in the brain after nasal administration of NEs.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [58]
Resveratrol nanoemulsions produced significantly high ex vivo trans-nasal mucosal fluxes on porcine nasal mucosa.
“Significantly high ex vivo trans-nasal mucosal fluxes were found using a Franz diffusion cell on porcine nasal mucosa.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels
Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892 · see citing works
Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent
Sedlak, J., & Lindsay, R. H. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90092-4 · Cited by 8,092 · see citing works
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,893 · see citing works
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,394 · see citing works
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239 · see citing works
Neuropsychopharmacology: The Fifth Generation of Progress
Sagduyu, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,023 · see citing works
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482 · see citing works
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 470 · see citing works
Effect of sulfhydryl reagents on peroxidation in microsomes
Utley, H. G., Bernheim, F., & Hochstein, P. E. (1967) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(67)90273-1 · Cited by 446 · see citing works
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Jin, F. J., Wu, Q., Lu, Y., Gong, Q., & Shi, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.005 · Cited by 384 · see citing works
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359 · see citing works
Self-citationDoes levodopa slow or hasten the rate of progression of Parkinson’s disease?
Fahn, S., & and the Parkinson Study Group (2005) · Journal of Neurology · doi:10.1007/s00415-005-4008-5 · Cited by 348 · see citing works
Pathogenesis of Parkinson's disease
Hirsch, E. C., Jenner, P., & Przedborski, S. (2013) · Movement Disorders · doi:10.1002/mds.25032 · Cited by 336 · see citing works
Khan, M. M., Ahmad, A., Ishrat, T., Khan, M. B., Hoda, M. N., Khuwaja, G., Raza, S. S., Khan, A., Javed, H., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.031 · Cited by 279 · see citing works
Nanoemulsions: the properties, methods of preparation and promising applications
Koroleva, M. Y., & Yurtov, E. V. (2012) · Russian Chemical Reviews · doi:10.1070/rc2012v081n01abeh004219 · Cited by 269 · see citing works
Venlafaxine loaded chitosan NPs for brain targeting: Pharmacokinetic and pharmacodynamic evaluation
Haque, S., Md, S., Fazil, M., Kumar, M., Sahni, J. K., Ali, J., & Baboota, S. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.02.051 · Cited by 161 · see citing works
Self-citationOxidative Stress and Microglial Cells in Parkinson's Disease
Peterson, L. J., & Flood, P. M. (2012) · Mediators of Inflammation · doi:10.1155/2012/401264 · Cited by 161 · see citing works
Physiological measurements using ultra-high field fMRI: a review
Francis, S., & Sánchez-Panchuelo, R.-M. (2014) · Physiological Measurement · doi:10.1088/0967-3334/35/9/r167 · Cited by 141 · see citing works
Wang, Y., Xu, H., Fu, Q., Ma, R., & Xiang, J. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.02.025 · Cited by 129 · see citing works
Ganta, S., Devalapally, H., & Amiji, M. (2010) · Journal of Pharmacy and Science · doi:10.1002/jps.22157 · Cited by 125 · see citing works
Fernández-Campos, F., Calpena, A. C., Delgado, G. R., Serrano, O. L., & Naveros, B. C. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23249 · Cited by 91 · see citing works
Sharma, S., Sahni, J. K., Ali, J., & Baboota, S. (2014) · Drug Delivery · doi:10.3109/10717544.2014.893382 · Cited by 87 · see citing works
Self-citationMd, S., Haque, S., Fazil, M., Kumar, M., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.894504 · Cited by 84 · see citing works
Self-citationInhaler technique and patient's preference for dry powder inhaler devices
Lavorini, F., & Fontana, G. A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.846907 · Cited by 82 · see citing works
Verma, R., & Nehru, B. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.04.001 · Cited by 66 · see citing works
Mustafa, G., Baboota, S., Ahuja, A., & Ali, J. (2012) · Current Nanoscience · doi:10.2174/157341312800620331 · Cited by 56 · see citing works
Self-citationRationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease
Schapira, A. H. V., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10514 · Cited by 50 · see citing works
Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats
Rex, A., Schickert, R., & Fink, H. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.001 · Cited by 48 · see citing works
Kumar, A., Ahuja, A., Ali, J., & Baboota, S. (2012) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2012.6620 · Cited by 39 · see citing works
Self-citationMedhi, B., Prakash, A., & Chopra, K. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.121374 · Cited by 18 · see citing works
A glass of red wine to improve mitochondrial biogenesis? Novel mechanisms of resveratrol
Szabo, G. B. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00471.2009 · Cited by 11 · see citing works
Mustafa, G., Baboota, S., Ali, J., Kumar, N., Singh, T., Bhatnagar, A., & Ahuja, A. (2012) · Science of Advanced Materials · doi:10.1166/sam.2012.1364 · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 300 · see citing works
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269 · see citing works
Molecular mechanisms of anticancer effect of rutin
Imani, A., Maleki, N., Bohlouli, S., Kouhsoltani, M., Sharifi, S., & Dizaj, S. M. (2020) · Phytotherapy Research · doi:10.1002/ptr.6977 · Cited by 241 · see citing works
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Pires, P. C., & Santos, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.047 · Cited by 228 · see citing works
Angelova, A., Garamus, V. M., Angelov, B., Tian, Z., Li, Y., & Zou, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.04.006 · Cited by 211 · see citing works
Nanodelivery of Natural Antioxidants: An Anti-aging Perspective
Vaiserman, A. M., Koliada, A. K., Zayachkivska, A., & Lushchak, O. V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00447 · Cited by 213 · see citing works
Gaba, B., Khan, T. M., Haider, M. F., Alam, T., Baboota, S., Parvez, S., & Ali, J. (2019) · BioMed Research International · doi:10.1155/2019/2382563 · Cited by 181 · see citing works
Self-citationNanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 185 · see citing works
Polyphenols in Metabolic Diseases
Gasmi, A., Mujawdiya, P. K., Noor, S., Lysiuk, R., Darmohray, R., Piscopo, S., Lenchyk, L. V., Antonyak, H., Dehtiarova, K., Shanaida, M., et al. (2022) · Molecules · doi:10.3390/molecules27196280 · Cited by 183 · see citing works
Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment
Andrade, S., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01261 · Cited by 173 · see citing works
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 172 · see citing works
Teixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.01.005 · Cited by 132 · see citing works
Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion
Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.030 · Cited by 124 · see citing works
Rakotoarisoa, M., Angelov, B., Garamus, V. M., & Angelova, A. (2019) · ACS Omega · doi:10.1021/acsomega.8b03101 · Cited by 122 · see citing works
Paiva‐Santos, A. C., Pereira, I., Pereira‐Silva, M., Ferreira, L., Caldas, M., Collado-González, M., Magalhães, M., Figueiras, A., Ribeiro, A. J., & Veiga, F. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.030 · Cited by 121 · see citing works
Ganesan, P., Ko, H.-M., Kim, I., & Choi, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93918 · Cited by 119 · see citing works
Dai, Y., Guo, Y., Tang, W., Chen, D., Xue, L., Chen, Y., Guo, Y., Wei, S., Wu, M., Dai, J., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02501-9 · Cited by 116 · see citing works
Kumar, S., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/43/435101 · Cited by 115 · see citing works
Self-citationBalakrishnan, R., Azam, S., Cho, D.-Y., Su-Kim, I., & Choi, D. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6680935 · Cited by 117 · see citing works
Recent progress in nanocarriers for direct nose to brain drug delivery
Emad, N. A., Ahmed, B., Alhalmi, A., Alzobaidi, N., & Al-Kubati, S. S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102642 · Cited by 109 · see citing works
Pires, P. C., Rodrigues, M., Alves, G., & Santos, A. O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030588 · Cited by 105 · see citing works
Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges
Karami, Z., Zanjani, M. R. S., & Hamidi, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.021 · Cited by 102 · see citing works
Pandey, Y. R., Kumar, S., Gupta, B. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/2/025102 · Cited by 96 · see citing works
Self-citationPersonalized nanomedicine for CNS diseases
Kaushik, A., Jayant, R. D., Bhardwaj, V., & Nair, M. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.010 · Cited by 95 · see citing works
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles
Trotta, V., Pavan, B., Ferraro, L., Beggiato, S., Traini, D., dos Reis, L. G., Scalia, S., & Dalpiaz, A. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.02.010 · Cited by 86 · see citing works
A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson’s Disease
Mittal, P., Dhankhar, S., Chauhan, S., Garg, N., Bhattacharya, T., Ali, M., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M. M., Ahmad, W., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16070908 · Cited by 82 · see citing works
Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Alhakamy, N. A., & Md, S. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.129721 · Cited by 80 · see citing works
Guerzoni, L. P. B., Nicolas, V., & Angelova, A. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2080-4 · Cited by 80 · see citing works
Fakhri, S., Abdian, S., Zarneshan, S. N., Moradi, S. Z., Farzaei, M. H., & Abdollahi, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s347187 · Cited by 80 · see citing works
Zamanian, M. Y., Romero‐Parra, R. M., Soltani, A., Kujawska, M., Mustafa, Y. F., Raheem, G., Al-Awsi, L., Lafta, H. A., Taheri, N., Heidari, M., et al. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08409-1 · Cited by 78 · see citing works
Role of nanostructures in improvising oral medicine
Ghosh, S., Ghosh, S., & Sil, P. C. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.04.004 · Cited by 76 · see citing works
Khatri, D. K., Preeti, K., Tonape, S., Bhattacharjee, S., Patel, M., Shah, S., Singh, P. K., Srivastava, S., Gugulothu, D., Vora, L., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x20666220507022701 · Cited by 75 · see citing works
Sharma, B., Iqbal, B., Kumar, S., Ali, J., & Baboota, S. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01964-3 · Cited by 74 · see citing works
Self-citationKuo, Y., Wang, I.-H., & Rajesh, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.015 · Cited by 74 · see citing works
Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability
Nagi, A., Iqbal, B., Kumar, S., Sharma, S., Ali, J., & Baboota, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.05.019 · Cited by 74 · see citing works
Self-citationKumar, S., Dang, S., Nigam, K., Ali, J., & Baboota, S. (2018) · Rejuvenation Research · doi:10.1089/rej.2017.2035 · Cited by 70 · see citing works
Self-citationSilymarin-Loaded Nanostructured Lipid Carrier Gel for The Treatment of Skin Cancer
Iqbal, B., Ali, J., Ganguli, M., Mishra, S., & Baboota, S. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0235 · Cited by 69 · see citing works
Self-citationIntranasal delivery of paeoniflorin nanocrystals for brain targeting
Wu, C., Li, B., Zhang, Y., Chen, T., Chen, C., Jiang, W., Wang, Q., & Chen, T. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.11.002 · Cited by 69 · see citing works
Sharma, S., Rabbani, S. A., Narang, J. K., Pottoo, F. H., Ali, J., Kumar, S., & Baboota, S. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104890 · Cited by 69 · see citing works
Self-citationAngelova, A., Drechsler, M., Garamus, V. M., & Angelov, B. (2019) · ChemNanoMat · doi:10.1002/cnma.201900468 · Cited by 68 · see citing works
Hasan, N., Imran, M., Sheikh, A., Tiwari, N., Jaimini, A., Kesharwani, P., Jain, G. K., & Ahmad, F. J. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116454 · Cited by 67 · see citing works
Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 66 · see citing works
Kuk, D.-H., Ha, E., Ha, D.-H., Sim, W., Lee, S.-K., Jeong, J.-S., Kim, J. S., Baek, I., Park, H., Choi, D. H., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120688 · Cited by 65 · see citing works
Pangeni, R., Kang, S.-W., Oak, M., Park, E., & Park, J. W. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.059 · Cited by 66 · see citing works
Self-citationIntranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Saha, P., Kathuria, H., & Pandey, M. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.021 · Cited by 65 · see citing works
Wahba, M. G. F., Messiha, B. A. S., & Abo‐Saif, A. A. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1125931 · Cited by 64 · see citing works
Shah, P., Dubey, P., Vyas, B., Kaul, A., Mishra, A. K., Chopra, D., & Patel, P. V. (2021) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2021.1939709 · Cited by 65 · see citing works
Therapeutic applications of resveratrol nanoformulations
Arora, D., & Jaglan, S. (2017) · Environmental Chemistry Letters · doi:10.1007/s10311-017-0660-0 · Cited by 60 · see citing works
Pardeshi, C. V., & Belgamwar, V. S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.09.032 · Cited by 60 · see citing works
Sharma, S., Narang, J. K., Ali, J., & Baboota, S. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/37/375101 · Cited by 59 · see citing works
Self-citationAshrafizadeh, M., Javanmardi, S., Moradi-Ozarlou, M., Mohammadinejad, R., Farkhondeh, T., Samarghandian, S., & Garg, M. (2020) · Bioscience Reports · doi:10.1042/bsr20200257 · Cited by 58 · see citing works
Fabrication of a Thermosensitive In Situ Gel Nanoemulsion for Nose to Brain Delivery of Temozolomide
Bayanati, M., Khosroshahi, A. G., Alvandi, M., & Mahboobian, M. M. (2021) · Journal of Nanomaterials · doi:10.1155/2021/1546798 · Cited by 55 · see citing works
Ashhar, M. U., Kumar, S., Ali, J., & Baboota, S. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105035 · Cited by 53 · see citing works
Self-citationVitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson’s Disease
Wang, J., Yang, D., Yu, Y., Shao, G., & Wang, Q. (2016) · Nutrients · doi:10.3390/nu8030142 · Cited by 51 · see citing works
Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration
Martano, S., Matteis, V. D., Cascione, M., & Rinaldi, R. (2022) · Nanomaterials · doi:10.3390/nano12142337 · Cited by 51 · see citing works
Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases
Pérez-Araluce, M., Jüngst, T., Sanmartín, C., Prósper, F., Plano, D., & Mazo, M. M. (2024) · Biomimetics · doi:10.3390/biomimetics9010023 · Cited by 51 · see citing works
Application of Nanodiagnostics and Nanotherapy to CNS Diseases
Zhang, W., Wang, W., Yu, D. X., Xiao, Z., & He, Z. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0163 · Cited by 51 · see citing works
Advances in Nanomedicine for the Treatment of Alzheimer’s and Parkinson’s Diseases
Hernando, S., Gartziandia, O., Herrán, E., Pedraz, J. L., Igartúa, M., & Hernández, R. M. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0019 · Cited by 48 · see citing works
Pangeni, R., Choi, J. U., Panthi, V. K., Byun, Y., & Park, J. W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s167958 · Cited by 48 · see citing works
Self-citationFree radical biology in neurological manifestations: mechanisms to therapeutics interventions
Tripathi, R. S., Gupta, R. V., Sahu, M., Srivastava, D., Das, A., Ambasta, R. K., & Kumar, P. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16693-2 · Cited by 52 · see citing works
Fonseca‐Santos, B., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119832 · Cited by 46 · see citing works
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
Mistretta, M., Farini, A., Torrente, Y., & Villa, C. (2023) · Brain · doi:10.1093/brain/awad014 · Cited by 43 · see citing works
Krauss, I. R., Imperatore, R., Santis, A. D., Luchini, A., Paduano, L., & D’Errico, G. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.04.032 · Cited by 44 · see citing works
Gupta, B. K., Kumar, S., Kaur, H., Ali, J., & Baboota, S. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.1959 · Cited by 44 · see citing works
Self-citationNose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases
Bonferoni, M. C., Rassu, G., Gavini, E., Sorrenti, M., Catenacci, L., & Giunchedi, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121246 · Cited by 42 · see citing works
Nanoscaled Dispersed Systems Used in Drug-Delivery Applications
Cheaburu-Yılmaz, C. N., Karasulu, H. Y., & Yılmaz, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813932-5.00013-3 · Cited by 41 · see citing works
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Jalili, C., Kiani, A., Gholami, M., Bahrehmand, F., Fakhri, S., Kakehbaraei, S., & Kakebaraei, S. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12127 · Cited by 43 · see citing works
Sirtuins as modifiers of Parkinson's disease pathology
Tang, B. L. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23806 · Cited by 40 · see citing works
Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats
Locatelli, F. M., Kawano, T., Iwata, H., Aoyama, B., Eguchi, S., Nishigaki, A., Yamanaka, D., Tateiwa, H., Shigematsu-Locatelli, M., & Yokoyama, M. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.08.006 · Cited by 40 · see citing works
Patel, M. R., Patel, R. B., & Thakore, S. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813741-3.00030-3 · Cited by 39 · see citing works
A comprehensive review of nano drug delivery system in the treatment of CNS disorders
Spandana, K. M. A., Bhaskaran, M., Karri, V. V. S. N. R., & Natarajan, J. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101628 · Cited by 40 · see citing works
Chopra, H., Bibi, S., Islam, F., Ahmad, S. U., Olawale, O. A., Alhumaydhi, F. A., Marzouki, R., Baig, A. A., & Emran, T. B. (2022) · Journal of Nanomaterials · doi:10.1155/2022/3083728 · Cited by 39 · see citing works
Qamar, Z., Ashhar, M. U., Annu, Qizilbash, F. F., Sahoo, P. K., Ali, A., Ali, J., & Baboota, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121131 · Cited by 38 · see citing works
Self-citationAli, M. H. H., Messiha, B. A. S., & Abdellatif, H. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1060247 · Cited by 37 · see citing works
Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?
Rehman, S., Nabi, B., Zafar, A., Baboota, S., & Ali, J. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1684895 · Cited by 35 · see citing works
Self-citationWaqar, M. A., Zaman, M., Hameed, H., Jamshaid, M., Irfan, A., Shazly, G. A., Paiva‐Santos, A. C., & Jardan, Y. A. B. (2023) · ACS Omega · doi:10.1021/acsomega.3c04444 · Cited by 34 · see citing works
Ashhar, M. U., Vyas, P., Vohora, D., Sahoo, P. K., Nigam, K., Dang, S., Ali, J., & Baboota, S. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121683 · Cited by 34 · see citing works
Self-citationBouzo, B. L., Calvelo, M., Martín‐Pastor, M., García‐Fandiño, R., & de la Fuente, M. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c02731 · Cited by 33 · see citing works
Grape By-Products in Sustainable Cosmetics: Nanoencapsulation and Market Trends
Castro, M. L., Ferreira, J. P., Pintado, M., Ramos, O. L., Borges, S., & Baptista-Silva, S. (2023) · Applied Sciences · doi:10.3390/app13169168 · Cited by 32 · see citing works
Allen, E. N., Potdar, S., Tapias, V., Parmar, M. S., Mizuno, C. S., Rimando, A. M., & Cavanaugh, J. E. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.015 · Cited by 32 · see citing works
Nanoemulsions-Based Drug Delivery for Brain Tumors
Ding, Z., Jiang, Y., & Liu, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00012-9 · Cited by 31 · see citing works
Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition
Gorain, B., Rajeswary, D. C., Pandey, M., Kesharwani, P., Kumbhar, S. A., & Choudhury, H. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200313125613 · Cited by 30 · see citing works
Ahmed, B., Rizwanullah, M., Mir, S. R., Akhtar, M. S., & Amin, S. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac9267 · Cited by 32 · see citing works
Nevins, S., McLoughlin, C. D., Oliveros, A., Stein, J. B., Rashid, M. A., Hou, Y., Jang, M., & Lee, K. (2023) · Small · doi:10.1002/smll.202300744 · Cited by 30 · see citing works
Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
Bicker, J., Fortuna, A. C., Alves, G., & Falcão, A. C. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115101544 · Cited by 30 · see citing works
Potential applications of nanomedicine for treating Parkinson's disease
Shankar, J., Geetha, K. M., & Wilson, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102793 · Cited by 29 · see citing works
Development and Characterization of Resveratrol Nanoemulsions Carrying Dual-Imaging Agents
Herneisey, M., Williams, J. M., Mirtič, J., Liu, L., Potdar, S., Bagia, C., Cavanaugh, J. E., & Janjic, J. M. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0050 · Cited by 28 · see citing works
Li, Q., Cheng, Y., Bi, M., Lin, H., Chen, Y., Zou, Y., Liu, Y., Kang, H., & Guo, Y. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.05.009 · Cited by 27 · see citing works
Nanophytomedicines as Therapeutic Agents for Parkinson’s Disease
Burns, J., Buck, A. C., Souza, S. D., Dube, A., & Bardien, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c04862 · Cited by 26 · see citing works
Lipid-based nanoparticles for drug delivery in Parkinson’s disease
Cai, H., Liu, D., Xue, W.-W., Ma, L., Xie, H.-T., & Ning, K. (2024) · Translational Neuroscience · doi:10.1515/tnsci-2022-0359 · Cited by 26 · see citing works
Mohammad, Khan, U. A., Warsi, M. H., Alkreathy, H. M., Karim, S., Jain, G. K., & Ali, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1188470 · Cited by 25 · see citing works
Transnasal-brain delivery of nanomedicines for neurodegenerative diseases
Zhang, X., Wang, M., Liu, Z., Wang, Y., Chen, L., Guo, J., Zhang, W., Zhang, Y., Yu, C., Bie, T., et al. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1247162 · Cited by 23 · see citing works
Pharmacokinetic Study and Optimal Formulation of New Anti-Parkinson Natural Compound Schisantherin A
Sa, F., Guo, B. J., Li, S., Zhang, Z. J., Chan, H. M., Zheng, Y., & Lee, S. M. (2015) · Parkinson s Disease · doi:10.1155/2015/951361 · Cited by 23 · see citing works
Singh, A., Ahmad, I., Ahmad, S., Iqbal, Z., & Ahmad, F. J. (2016) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2016.1151032 · Cited by 23 · see citing works
Yin, H., Wang, H., Zhang, H., Gao, N., Zhang, T., & Yang, Z. R. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9726-9 · Cited by 23 · see citing works
Pashirova, T. N., Burilova, E. A., Tagasheva, R. G., Zueva, I. V., Гибадуллина, Э. М., Nizameev, I. R., Sudakov, I. A., Vyshtakalyuk, A. B., Voloshina, A. D., Kadirov, M. K., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108753 · Cited by 21 · see citing works
Kumar, M., Nishad, D. K., Kumar, A., Bhatnagar, A., Karwasra, R., Khanna, K., Keerthana, S. V., Sharma, D., Dua, K., Mudaliar, V., et al. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1801870 · Cited by 21 · see citing works
Kiran, P., Debnath, S. K., Neekhra, S., Pawar, V. S., Khan, A., Dias, F., Pallod, S., & Srivastava, R. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1768 · Cited by 26 · see citing works
Samie, S. M. A., & Nasr, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821222-6.00011-7 · Cited by 21 · see citing works
Drug Delivery Systems and Strategies to Overcome the Barriers of Brain
Garg, Y., Kapoor, D. N., Sharma, A. K., & Bhatia, A. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612828666211222163025 · Cited by 20 · see citing works
- Authors
- Pangeni, R., Sharma, S., Mustafa, G., Ali, J., & Baboota, S.
- Affiliations
- Jamia Hamdard (IN)
- Corresponding author
- Baboota, Sanjula
- Venue
- Nanotechnology
- Publisher
- IOP Publishing
- Published
- 2014-11-13
- Volume
- 25
- Issue
- 48
- Pages
- 485102
- ISSN
- 0957-4484 (ISSN-L)
- 1361-6528
- OpenAlex
- W1967033368
- Cited by
- 192
- References
- 32
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 23 · 2023: 24 · 2022: 22 · 2021: 18 · 2020: 23 · 2019: 18 · 2018: 10 · 2017: 14 · 2016: 9 · 2015: 8
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nanotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- resveratrol, nanoemulsions, Parkinson's disease, vitamin E, brain targeting, intranasal drug delivery, oxidative stress, antioxidant activity, high-pressure homogenization, drug bioavailability, pharmacokinetics, lipid peroxidation, glutathione, superoxide dismutase, malondialdehyde, neuroprotection
- MeSH terms
- Resveratrol, Animals, Antioxidants, Biological Availability, Brain, Chemistry, Pharmaceutical, Emulsions, Female, Male, Parkinson Disease, Particle Size, Polysorbates, Solubility, Stilbenes, Swine, Viscosity, Vitamin E, Rats, Wistar, Oxidative Stress, Rats, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
